AI-designed “intrabodies” could unlock new treatments for Alzheimer’s, Parkinson’s and MND

Researchers have developed a new way to turn ordinary antibodies into tiny disease-fighting molecules that can work inside human cells, potentially opening new paths for treating Alzheimer’s, Parkinson’s, Huntington’s disease, and motor neurone disease.

Scientific signal separates durable discovery from noise — and often foreshadows policy and product.

ScienceDaily reported on this under science. RedScroll surfaces the signal with an extractive brief — not a reprint of the original article. Read the source for full reporting.